LWA
WST icon

Lenox Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Lenox Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-98
Closed -$15K – 808
2020
Q1 		$15K Buy
+98
New +$15.1K ﹤0.01% 307
2019
Q2 		– Sell
-78
Closed -$9K – 583
2019
Q1 		$9K Buy
78
+51
+189% +$5.3K ﹤0.01% 287
2018
Q4 		$3K Hold
27
– – ﹤0.01% 326
2018
Q3 		$3K Sell
27
-150
-85% -$16.8K ﹤0.01% 347
2018
Q2 		$18K Buy
177
+129
+269% +$11.9K ﹤0.01% 277
2018
Q1 		$4K Buy
48
+21
+78% +$1.96K ﹤0.01% 438
2017
Q4 		$3K Buy
+27
New +$2.65K ﹤0.01% 302

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return